PGLA/PEG Copolymer-Based Paclitaxel

A controlled-release, intratumoral paclitaxel formulation in which paclitaxel is incorporated into a thermosensitive, biodegradable triblock copolymer consisting of poly(lactide-co-glycolide) (PLGA) and polyethylene glycol (PEG). Upon intratumoral injection, paclitaxel is released slowly and continuously into tumor tissues from the gelled thermosensitive triblock copolymer over a period of 4 to 6 weeks; in tumor cells, paclitaxel binds to tubulin and inhibits the disassembly-assembly dynamics of microtubules, resulting in cell cycle arrest and cell death. The thermosensitive triblock copolymer component of this formulation transforms from a water-soluble polymer at room temperature to a water-insoluble, biodegradable gel depot at body temperature; intratumoral controlled-release of paclitaxel from the gel minimizes systemic exposure to paclitaxel and the paclitaxel toxicity profile. (NCI Thesaurus)

YOU MAY ALSO LIKE

PGK1 wt Allele

Human PGK1 wild-type allele is located in the vicinity of Xq13.3 and is approximately 64 kb in length. This allele, which encodes…

PGK1 Gene

This gene plays a role in glycolysis.

PGGT1B wt Allele

Human PGGT1B wild-type allele is located in the vicinity of 5q22.3 and is approximately 51 kb in length. This allele, which encodes…

PGGT1B Gene

This gene is plays a role in subcellular protein targeting and the post-translational modification of certain proteins.

PGG Beta-Glucan

An injectable formulation of the polysaccharide beta 1,3/1,6 glucan derived from the cell wall of the yeast Saccharomyces cerevisiae with potential…

PGF wt Allele

Human PGF wild-type allele is located within 14q24-q31 and is approximately 14 kb in length. This allele, which encodes placenta growth factor…